Keyphrases
Primate Model
100%
Genital
100%
Papillomavirus Infections
100%
Cervical Cancer
55%
High-risk Human Papillomavirus (HR-HPV)
55%
Macaque
33%
Genital Human Papillomavirus
22%
Macaque Model
22%
Specific Types
22%
Genital Warts
22%
HPV16
22%
Cervical Infection
22%
Developing Nations
11%
Serologic Assays
11%
Natural History
11%
Seroconversion
11%
New Therapies
11%
Public Health
11%
Rodent Models
11%
Medical Community
11%
Cervix Dysplasia
11%
Betapapillomavirus
11%
Prophylactic Vaccine
11%
Genital Cancer
11%
Immune Development
11%
Human Papillomavirus Types
11%
Pregenomic RNA (pgRNA)
11%
Therapeutic Modalities
11%
Public Health Risk
11%
Cold Chain
11%
High Cost
11%
Human Population
11%
High Risk
11%
Specific Intent
11%
Oncogenic Human Papillomavirus
11%
Next-generation Vaccines
11%
Neoplasia
11%
Persistent Infection
11%
United States
11%
Molecular Events
11%
Cervical Lesions
11%
Experimental Infection
11%
Cellular Environment
11%
Proviral DNA
11%
Cynomolgus Macaque
11%
Cervicovaginal
11%
Viral
11%
Developmental Research
11%
Host Immune Response
11%
Sexually Transmitted
11%
Tissue Culture Model
11%
Infection Risk Factors
11%
Immunology and Microbiology
Infection
100%
Papillomaviridae
100%
Wart Virus
41%
Macaca
29%
Genital Wart
11%
Ribonucleic Acid
5%
Macaca fascicularis
5%
Seroconversion
5%
Tissue Culture
5%
DNA Virus
5%
Alphapapillomavirus
5%
Host Immune Response
5%
Human Papillomavirus Type 18
5%
Human Papillomavirus Type 16
5%